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Abstract
Nowadays cognitive impairments are a growing unresolved medical issue which may accompany many diseases and therapies,
furthermore, numerous researchers investigate various neurobiological aspects of humanmemory to find possible ways to improve it.
Until any other method is discovered, in vivo studies remain the only available tool for memory evaluation. At first, researchers need
to choose a model of amnesia which may strongly influence observed results. Thereby a deeper insight into a model itself may
increase the quality and reliability of results. The most common method to impair memory in rodents is the pretreatment with drugs
that disrupt learning andmemory. Taking this into consideration, we compared the activity of agents commonly used for this purpose.
We investigated effects of phencyclidine (PCP), a non-competitive NMDA receptor antagonist, and scopolamine (SCOP), an
antagonist of muscarinic receptors, on short-term spatial memory and classical fear conditioning in mice. PCP (3 mg/kg) and
SCOP (1 mg/kg) were administrated intraperitoneally 30 min before behavioral paradigms. To assess the influence of PCP and
SCOP on short-term spatial memory, the Barnes maze test in C57BL/J6 mice was used. Effects on classical conditioning were
evaluated using contextual fear conditioning test. Additionally, spontaneous locomotor activity of mice was measured. These two
tests were performed in CD-1 mice. Our study reports that both tested agents disturbed short-term spatial memory in the Barnes maze
test, however, SCOP revealed a higher activity. Surprisingly, learning in contextual fear conditioning test was impaired only by SCOP.
Keywords Scopolamine . Phencyclidine . Barnes maze . Contextual fear conditioning paradigm . Freezing and grooming
behavior . Mice
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Introduction
Memory deficits belong to the most frequent impairments that
accompany psychiatric, neurological, or metabolic disorders,
including Alzheimer’s disease (Tromp et al. 2015), epilepsy
(Dupont 2015), diabetes mellitus (Sadanand et al. 2016), and
others. Moreover, cognitive decline can be a manifestation of
adverse effect of various drugs, for instance analgesics
(Finnerup et al. 2015), or antiepileptic drugs (Javed et al.
2015). Because impaired memory significantly worsens pa-
tients’ quality of life, much effort has been made to discover
and develop drugs with anti-amnesic properties.
In vitro assays have been found very useful for preliminary
studies on learning and memory phenomena, but to fully in-
vestigate neurobiological aspects of learning processes and
memory formation in living organisms, rodent models are
involved as the critical path at the preclinical stage of research.
In this area of experiments, several animal models mimick-
ing cognitive decline, as well as numerous behavioral tests for
its assessment have been introduced. These valuable research
tools enable to study various types of memory (Fig. 1) (Blaser
and Heyser 2015; Cho et al. 1999; Frankland et al. 1998;
Malikowska et al. 2017; Podkowa et al. 2016; Sałat et al.
2016; Stiedl et al. 2000; Sunyer et al. 2007).
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In our laboratory, we use passive avoidance (PA) task,
Morris water maze (MWM), radial-arm water maze
(RAWM), Barnes maze (BM), and novel object recognition
(NOR) task to study various aspects of learning and memory
processes and to discover compounds with potential anti-
amnesic properties (Malikowska et al. 2017; Podkowa et al.
2016; Salat et al. 2015, 2017a; Wilcock et al. 2004). Although
each of these tasks is burdened with some disadvantages,
using them together can provide complementary results.
In our previous studies we utilized PA,MWM, and RAWM
tests for the assessment of anti-amnesic properties of various
biologically active compounds (Košak et al. 2016;
Malikowska et al. 2017; Podkowa et al. 2016; Salat et al.
2015, 2017b). To induce memory deficits in mice, we used
intraperitoneal injections of scopolamine (SCOP) or phency-
clidine (PCP). These experiments confirmed pro-amnesic
properties of both SCOP and PCP. However, it should be
noted that the assessment of memory deficits was performed
using tasks involving aversive stimuli, i.e., high-stress level
conditions (PA: electric shock, and MWM, RAWM: water
immersion and repeated swimming sessions) which are
regarded as independent key factors responsible for the devel-
opment of stress and depression (Kato et al. 2016). In rodents,
water immersion with a subsequent measurement of
depression-like behavior (‘immobility’) is known as the
forced swim test (Porsolt et al. 1977). This assay is used to
reveal antidepressant-like activity of drugs. At the same time,
it points out that the assessment of animals’ cognition using
only water mazes may be confounded. This issue is particu-
larly important in the case of anticholinergic compounds, such
as SCOP which are known for their antidepressant-like prop-
erties both in animals (Petryshen et al. 2016; Podkowa et al.
2016) and humans (Rigal et al. 2016). Also, testing conditions
might significantly interfere with animals’ behavior, for ex-
ample, an electric shock utilized to generate fear-motivated
contextual learning and memorymay additionally induce anx-
iety (Bentefour et al. 2016; Stiedl et al. 2000).
Taking these issues into consideration, in the present re-
search we propose the use of BM to confirm potential useful-
ness of SCOP and PCP as tools to induce amnesia in rodents.
This study complements our previous research on SCOP and
PCP (Malikowska et al. 2017) and provides a deeper insight
into chemically induced models and their effects on short-term
spatial memory, contextual memory, as well as classical and
instrumental conditioning. Tested doses of SCOP and PCP
were selected based on our previous experiment
(Malikowska et al. 2017; Salat et al. 2015) and available liter-
ature data (Bonito-Oliva et al. 2016; Harrison et al. 2010;
Jiang et al. 2016; Klinkenberg and Blokland 2010; Komater
et al. 2005; Oyamada et al. 2015).
Fig. 1 Most popular in vivo assays used to study various types of memory
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The key advantage of BM over MWM or RAWM is that
BM is a dry-land maze able to assess spatial learning without
exposing animals to stress due to water immersion (Sunyer
et al. 2007). The impact of SCOP on memory impairments is
an area of extended studies. Although this muscarinic receptor
antagonist is used to induce memory impairments
(Klinkenberg and Blokland 2010; Haider et al. 2016; Jiang
et al. 2016; Podkowa et al. 2016; Salat et al. 2015), there is
also some bias about this agent, as the blockade of presynaptic
muscarinic M2 receptors might increase the release of acetyl-
choline (Felder 1995; Mohr et al. 2015; Quirion et al. 1994).
Hence, some authors propose the use of PCP as an alternative
tool to induce learning and memory deficits in rodents.
As a part of the present study, we also assess pro-amnesic
properties of intraperitoneally administered SCOP and PCP in
the contextual fear conditioning paradigm (CFC). Fear condi-
tioning is strongly associated with some psychiatric disorders
like phobias, or post-traumatic stress disorder (PTSD).
Recently, a strong link between PTSD and memory impair-
ments has been shown by Zhu and colleagues (Zhu et al.
2017). These authors investigated memory impairments in
PTSD-exposed rats, and they observed significant changes
in prefrontal cortex, hippocampus, and amygdala of stressed
animals. It has been also demonstrated that in patients suffer-
ing from PTSD hippocampal tissue—a key brain structure for
memory formation, is significantly reduced (Bennett et al.
2016). Based on these studies, it was concluded that in
PTSD fear generalization and abnormal fear responses condi-
tioned by trauma are evoked and associative learning in PTSD
patients could be extended and some cues apparently unrelat-
ed to traumatic events may evoke a strong fear response.
Of note, previous studies have shown that the delay or
lapse of a reaction to conditioned stimuli (i.e., context), which
is the source of fear, is not simple forgetting but an active
process called fear extinction (Furini et al. 2014; Kaplan and
Moore 2011). Thus, the use of CFC enables to achieve a more
detailed insight into the effects of SCOP and PCP on classical
conditioning.
Materials and Methods
Chemicals
SCOP hydrobromide (dose 1 mg/kg) and PCP hydrochlo-
ride (dose 3 mg/kg) were purchased from Sigma Aldrich
(Poland). For the in vivo tests, they were prepared in 0.9%
saline (Polfa Kutno, Poland) and were administered intra-
peritoneally (i.p.) 30 min before behavioral tests. Control
mice received 0.9% saline (i.p.). In the BM paradigm all
drugs tested were administered intraperitoneally 30 min
before every acquisition (training) session which was held
on days 1–4. On day 1, the administration of compounds
tested was done after an additional adaptation period, but
30 min before training. Drugs were not injected on day 5
when the final examination was performed. In the CFC
paradigm drugs were administered 30 min before condi-
tioning on the first day of this test. No drugs were admin-
istered on day two. In the locomotor activity test, the ad-
ministration of drugs was immediately followed by a 30-
min-lasting adaptation period. Next, the final examination
was conducted.
Animals and Housing Conditions
Behavioral experiments were carried out at the Department of
Pharmacodynamics, Faculty of Pharmacy, Jagiellonian
University Medical College in Krakow. Eight-week-old male
C57BL/6 J mice weighing between 18 and 22 g were pur-
chased from a licensed animal breeding farm (Staniszewska,
Ilkowice, Poland). Since there is evidence that C57BL/6 J
mice show advantages over CD-1 mice in spatial learning
and memory tasks which is due to their better visual skills as
compared to Swiss Albino CD-1 mice (Patil et al. 2009), these
mice were used in the BM task.
Male CD-1 Albino Swiss mice of the same age and body
weight were purchased from the animal breeding farm at the
Jagiellonian University, Faculty of Pharmacy in Krakow.
These mice were used in the locomotor activity and CFC tests.
The animals were housed in groups of six mice per cage at
room temperature of 22 ± 2 °C, under light/dark (12:12) cycle.
The animals had free access to food and water before experi-
ments. The ambient temperature of the room and humidity
(55 ± 5 °C) were kept consistent throughout the tests. For be-
havioral experiments the animals were selected randomly.
Experimental groups consisted of 6–10 animals. The experi-
ments were performed between 8 AM and 2 PM. Immediately
after in vivo assays, the animals were euthanized by cervical
dislocation. All procedures were approved by the Local Ethics
Committee of the Jagiellonian University in Krakow, and the
treatment of animals was in full accordance with ethical stan-
dards laid down in respective Polish and EU regulations
(Directive No. 86/609/EEC).
Behavioral Testing Paradigm
Barnes Maze Test
Spatial learning and memory in mice was assessed using BM
(Harrison et al. 2010; Komater et al. 2005; Sunyer et al. 2007).
This task was performed with the use of BM apparatus
(Panlab-Harvard Apparatus, Spain). It consists of a circular,
dry, open platform surface equipped with 18 holes around the
perimeter of the platform and a small dark recessed chamber
located under one of them. Visual extra-maze cues (pictures of
colored geometric figures with contrasting background,
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placed at a distance 1 m from the platform) were provided to
facilitate learning. Weak aversive stimuli (light (600 lx) and
fan) were applied to increase animals’ motivation to escape
from the circular platform (Paylor et al. 2001).
During the first 4 days of the experiment, the spatial acqui-
sition trial was performed. On the first day of the test, an
additional adaptation period preceded a proper trial. In this
phase, mice were individually placed in a cylindrical black
start chamber located in the middle of circular maze. Ten
seconds later the mouse was released from the start chamber,
the light and fan were turned on and the animal was gently
guided to the escape box (a small dark recessed chamber lo-
cated under the BM platform), where it remained for the next
2 min. This phase was not preceded by drugs injection.
In the spatial acquisition phase, each mouse was subjected
to four trials daily with keeping 15-min intervals between each
trial. Mice were injected with tested drugs or saline 30 min
before the first trial on each day of the acquisition phase. In
every trial, the mouse was placed in a cylindrical black start
chamber in the middle of BM. After 10 s, the mouse was
released from the start chamber, light and fan were turned on
and the mouse was allowed to explore the maze for 180 s.
During this phase, the number of primary errors (i.e., the num-
ber of errors before the mouse reached the escape box), total
errors (i.e., the number of all errors made during 180 s of test),
primary and total latencies (times) to find the escape box (i.e.,
time required to find and time required to enter the escape box,
respectively) were measured. If the mouse did not find the
escape box during 180 s, it was gently guided towards it.
Immediately after the mouse entered the box, the light and
fan were turned off and the mouse was allowed to stay in
the box for 1 min. On day 5, the assessment of reference
short-term memory was conducted (a drug-off probe trial).
The escape box was removed and replaced by a closed area
(plastic plate). Each mouse was placed in a cylindrical
black start chamber. After its removal, the mouse was
allowed to explore the maze for the next 90 s. Primary
errors, total errors, and latency time to reach the former
target (i.e., the escape box) location were recorded and
analyzed (Sunyer et al. 2007).
Activity Monitoring
Activity monitoring was performed using activity cages
(40 cm × 40 cm × 31 cm) supplied with I.R. horizontal and
vertical beam emitters (Activity Cage 7441, Ugo Basile,
Italy) connected to a counter measuring the number of light-
beam crossings. The mice were i.p. injected with SCOP
hydrobromide (1 mg/kg), PCP hydrochloride (3 mg/kg).
Control mice were given saline. Then, the animals were
placed in the activity cages located in a sound attenuated room
for 30min habituation period. Next, the final examination was
performed. Software analysis enabled the measurement of
ambulations and rearing during the next 30 min at 6-min in-
tervals (Cartmell et al. 2000). Drugs or saline were adminis-
tered 30 min before the final examination.
Contextual Fear Conditioning Paradigm
This test was performed following the methods described by
three research groups: Stiedl et al. (2000), Brown et al. (2011)
and Bentefour et al. (2016). Contextual fear conditioning was
performed using apparatus (Panlab-Harvard Apparatus,
Spain) which consists of a large white-painted illuminated
compartment (26 cm × 26 cm × 34 cm) and a small black-
painted compartment (13 cm × 7.5 cm × 7.5 cm) which are
separated from each other by a guillotine gate (5 cm × 5 cm).
The floor of the dark compartment enabled delivery of electric
shocks.
On the first day of the experiment, 30 min after the
injection of SCOP, PCP, or saline, every mouse was placed
individually in a white compartment and was allowed to
explore the whole apparatus for 2 min (the guillotine gate
remained open). Afterwards, the mouse was gently moved
into the dark compartment and guillotine gate closed.
Then, three electric shocks (current intensity: 0.7 mA;
stimulus duration: 3 s) at an interval of 1 min were deliv-
ered to the animals, except for the CFC electric shocks not-
subjected control group, i.e., the mice of CFC electrics
shocks not-subjected control group were allowed to ex-
plore the apparatus for 2 min, then they were gently moved
to dark compartment, where they remained for the next
3 min and no electric shock was delivered. In contrast,
electric shocks-subjected control was exposed to both ex-
ploration and an electric shock. Next, the mice were placed
in their home cages. On the second day, neither SCOP nor
PCP was administered. Mice were individually placed in
the white compartment and were allowed to explore both
compartments for 3 min (the guillotine gate was open). For
this period, the duration of freezing behavior (i.e., com-
plete immobility, excluding breathing and heart-beating
movements), as an indicator of anxiety, was measured.
Moreover, the duration of grooming behavior was also
recorded.
Statistical Analysis
Data analysis of the results was carried out using GraphPad
Prism software (v. 5, CA, USA). Numerical results from be-
havioral tests are expressed as mean ± SEM. For the statistical
analysis, one-way analysis of variance (ANOVA) was used,
followed by Dunnett’s post hoc comparison, or two-way re-
peated measures ANOVA, followed by Bonferroni’s multiple
comparison. P < 0.05 was considered significant.
434 Neurotox Res (2018) 34:431–441
Results
Barnes Maze Test
In this task, the influence of SCOP and PCP on short-term
memory was assessed. Results of the probe trial and the
acquisition trial are shown in Figs. 2 and 3, respectively.
During the acquisition trial, primary errors were influenced
both by factors, i.e., drug (F [2.15] = 16.41; p = 0.0002)
and time (F [3.45] = 4.08; p = 0.012), however, overall in-
teraction was considered not significant (F [6.45] = 0.45;
p = 0.8436) (Fig. 3a). The administration of SCOP entailed
a statistically significant increase in primary errors during
each day of the acquisition phase (day 1: p < 0.01, day 2:
p < 0.01, day 3: p < 0.05, day 4: p < 0.01) (Fig. 3a). In
contrast to this, PCP significantly (p < 0.05) increased the
number of primary errors only on day 1. Total errors were
influenced only by drug administration (F [2.15] = 10.23;
p = 0.0016). The injection of SCOP increased the number
of total errors on days 3 (p < 0.01) and 4 (p < 0.01) of the
acquisition trial (Fig. 3a). The comparison of daily scores
of the vehicle-treated group and drug-treated groups
showed no influence of SCOP or PCP on either primary,
or total latency when average values in consecutive ses-
sions were compared (i.e., daily trials 1–4 averaged across
the four acquisition days). Primary errors were influenced
by the drug factor (F [2.15] = 16.41; p = 0.0002), but not
time factor (F [3.45] = 1.27; p = 0.2949) (Fig. 3b). Overall
interaction was considered not significant (F [6.45] = 1.98;
p = 0.0886). SCOP led to a statistically significant reduc-
tion of primary errors in the first (p < 0.01), second (p <
0.001), third (p < 0.01), and fourth (p < 0.001) sessions,
whereas PCP caused a significant effect only in the first
(p < 0.01) and third (p < 0.05) sessions. Also total errors
were significantly influenced (drug effect: F [2.15] = 9.91;
p = 0.0018; time effect: F [3.45] = 2.47; p = 0.0743), but
overall interaction was not significant (F [6.45] = 0.7; p =
0.6476) (Fig. 3b). SCOP caused a statistically significant
reduction of total errors in the first (p < 0.01), second (p <
0.05), third (p < 0.01) and fourth (p < 0.01) sessions,
whereas PCP caused a significant effect only in the first
(p < 0.05) and third (p < 0.05) sessions.
In the probe (drug-off) trial on day 5, primary errors were
influenced by both SCOP and PCP (F [2.15] = 6.848; p =
0.0077). However, latency time to reach the former target
(i.e., the escape box) location was significantly altered only
in the SCOP-treated group (F [2.15] = 5.610; p = 0.0152).
Activity Monitoring
In this test, the number of ambulations was measured. Both
time and drugs influenced the results in a statistically signifi-
cant manner (F [4.76] = 6.86; p < 0.0001; F [2.19] = 6.53; p <
0.01, respectively). An overall interaction was considered sig-
nificant (F [8.76] = 2.59; p < 0.05). Compared to the control
group, SCOP and PCP caused statistically significant in-
creases in animals’ locomotor activity only during the first
18 min of the test (Fig. 4).
Contextual Fear Conditioning Paradigm
In this test, duration of freezing and grooming behavior was
measured. Both, treatment and time affected freezing behavior
in a statistically significant manner (drug effect: F [3.35] =
9.77; p < 0.0001; time effect: F [1.35] = 30.33; p < 0.0001)
and the interaction was considered significant (F [3.35] =
9.98; p < 0.0001). On the first day of the test, almost none of
the animals presented freezing behavior. A control group, that
was not exposed to an electric stimulus, presented no freezing
behavior on both days of the experiment. On the second day of
Fig. 2 Effects of SCOP (1 mg/kg, i.p.) and PCP (3 mg/kg, i.p.) on the
number of primary errors, total errors and latency to reach the former
target (i.e. the escape box) location measured in BM test performed on
day 5. Results are shown as themean number of errors ± SEM and latency
time [s] ± SEM to reach the former target (the escape box) location.
Statistical analysis: one-way analysis of variance (ANOVA), followed
byDunnett’s multiple comparison. Significance vs. vehicle-treated group:
*p < 0.05; **p < 0.01
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the experiment, the control group subjected to electric shocks
presented a marked and statistically significant prolongation
of freezing behavior when compared to control mice not sub-
jected to electric shocks in CFC procedure (significant at
p < 0.0001). The SCOP-treated group presented a statistically
significant reduction of freezing behavior when compared to
control mice subjected to electric shocks in CFC (p < 0.0001).
Interestingly, there was no effect of PCP on duration of freez-
ing behavior, and these results correlated with those of electric
shocks-subjected CFC control group (Table 1).
Discussion
In the present study, we used a dry-land maze (i.e., the BM
task) and CFC paradigm to assess memory-impairing poten-
tial of SCOP and PCP inmice. The doses of both agents (1 and
3 mg/kg, respectively) used in this research were selected
based on our previous studies (Malikowska et al. 2017; Salat
et al. 2015) and available literature data (Harrison et al. 2010;
Jiang et al. 2016; Klinkenberg and Blokland 2010; Komater
et al. 2005).
In our earlier research (Malikowska et al. 2017), the ability
of SCOP, PCP, and biperiden (BIP) to induce amnesia in mice
was compared. In these experiments, SCOP and PCP demon-
strated a more prominent than BIP pro-amnesic activity;
hence, these two drugs were chosen to assess their effect on
short-term spatial memory in BM and CFC. In BM task,
C57BL/6 J mice were used, because of their good visual skills
required for spatial memory examination (Puzzo et al. 2014),
while CD-1 mice were utilized in CFC paradigm.
Many researchers indicate that there are two parameters
crucial for BM, namely: primary latency (time) and primary
errors, that is time required and number of errors made before
the animal reaches the target—i.e. the escape box (Sunyer
et al. 2007). The administration of SCOP resulted in the
increase in both parameters, i.e., primary errors and prima-
ry latency (time). In other behavioral tests, i.e., MWM and
RAWM corresponding results for SCOP used at the same
dose were obtained (Podkowa et al. 2016; Salat et al.
2015). Furthermore, both SCOP and PCP were also highly
active in a fear-conditioned behavioral test assessing con-
textual memory, namely, the passive avoidance task
(Malikowska et al. 2017).
Voluntary entrance into the electric shock-associated area,
which is directly measured by PA test is identified with an
instrumental conditioning, whereas involuntary location could
be more associated with a classical conditioning—there is an
aversive enhancement of context, but not mouse reaction (i.e.,
entrance to the shock-associated area). It is confirmed by our
previous study where the observed effects were different from
these currently obtained, i.e., in the PA test PCP strongly im-
paired both contextual memory and instrumental condition-
ing. In contrast to this, in the current experiment only SCOP
interfered with place-conditioning, which confirmed that both
these tests involve different types of learning. To achieve the
most accurate comparison, we decided to perform contextual
fear conditioning with the use of the PA apparatus, with a view
to keep the constant conditions of both tests.
This previous study (Malikowska et al. 2017) revealed that
PCP might be slightly more active than SCOP but both stud-
ied compounds interfered with associative learning related to
instrumental conditioning which is a source of avoidance be-
havior observed in the PA task (Furini et al. 2014). Following
other researchers (Furini et al. 2014; Kaplan and Moore 2011)
Fig. 3 Effects of SCOP (1 mg/kg, i.p.) and PCP (3 mg/kg, i.p.) on
working and short-term memory during the acquisition phase of the
BM test, performed on days 1–4. Number of errors and latency time
during consecutive days of experiment (i.e., averages of all trials
performed on each day 1–4) (a), or consecutive daily sessions (i.e., the
daily trials averaged across the four acquisition days; e.g., an average of
trial 1 on acquisition days 1–4, an average of trial 2 on days 1–4, etc. (b).
Results are shown as the mean number of errors ± SEM and latency time
[s] ± SEM to enter or recognize the escape box. Statistical analysis: two-
way repeated measures ANOVA, followed by Bonferroni’s multiple
comparison. Significance vs. vehicle-treated group: *p < 0.05;
**p < 0.01; ***p < 0.001
Fig. 4 Influence of SCOP (1 mg/kg, i.p.) and PCP (3 mg/kg, i.p.) on
animals’ locomotor activity. Results are shown as the mean number of
ambulation (± SEM). Statistical analysis: two-way repeated measures
ANOVA, followed by Bonferroni’s multiple comparisons. Significance
vs. vehicle-treated group: *p < 0.05; **p < 0.01; ***p < 0.001
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and considering learning extinction as an active process that
involves long-term potentiation and long-term depression, the
stronger negative effect of PCP, a NMDA receptor antagonist
in the PA task remains unclear.
To investigate further this issue, we have also assessed the
influence of SCOP and PCP on fear conditioning using the
CFC test. Interestingly, in this experiment, SCOP was more
active than PCP. SCOP-treated mice did not associate the con-
text with aversive stimuli, and presented the same degree of
anxiety-related behavior (measured as duration of freezing
behavior) as vehicle-treated group not exposed to electric
stimulus. Thus, it could be assumed that SCOP may alleviate
contextual fear. On the other hand, the SCOP-injected group
was the only one that presented a strong prolongation of
grooming time, which might be a manifestation of increased
stress and anxiety (Kalueff and Tuohimaa 2005; Sałat et al.
2016). These data remain apparently inconsistent, i.e., SCOP
in the same test reduced contextual fear measured as freezing
behavior and enhanced self-grooming that is usually associat-
ed with stress. Intensified grooming may be a result of in-
creased locomotor activity and stereotypies; however, both
SCOP and PCP are known to induce these effects, so it does
not explain the difference observed (Haller et al. 2005,
Laviolette et al. 2000). More recent data indicate that the cor-
relation between situational aversiveness and intensity of
grooming is represented by inverted U-shaped function
(Fernandez-Teruel and Estanislau 2016; Song et al. 2016).
According to these reports, both low and high level of aver-
siveness may result in reduced self-grooming. Strongly inten-
sified anxiety/stress is thought to induce freezing behavior and
it precludes grooming at the same time. Otherwise, in moder-
ately stressful situations, the grooming behavior reaches the
highest intensity. Interestingly, it is usually associated with a
novel or changing environment and this might be a potential
explanation for the results obtained in the CFC test—in-
creased grooming observed in SCOP-treated mice may be a
consequence of moderate stress in SCOP-treated memory-
impaired mice which consider the compartment of CFC appa-
ratus as the novel one. It suggests that SCOP-treated mice, in
contrary to PCP-treated mice, did not remember the first ex-
position to CFC apparatus, which is further confirmed by
reduced contextual fear.
A negative effect of PCP on memory is widely known
(Morris 2013; Vyklicky et al. 2014; Jones et al. 1990). In the
present research, in the probe trial of BM, PCP influenced
only primary errors, whereas it increased the number of total
errors insignificantly. In BM task, PCP compared to SCOP
was less effective. PCP did not increase either primary or total
time to reach the escape box and this suggests that it might
impair only the quality of memory, but not the speed of recall.
Alternatively, this effect might be a result of psychomotor
stimulation caused by PCP (Figs. 3 and 4). It was also reported
that the blockade of NMDA receptors is involved in fear con-
ditioning and reduces fear in rats (Gilmartin and Helmstetter
2010; Laurent and Westbrook 2009; Zimmerman and Maren
2010). However, it should be noted that in these studies a
competitive antagonist of NMDA receptors (APV) was used,
whereas we used PCP which is an uncompetitive channel
blocker. Furthermore, additional properties of PCP, such as
inhibition of nicotinic acetylcholine receptors (Thomsen
et al. 2009; Hashimoto et al. 2006), AMPA receptors
(Katayama et al. 2007), and interaction with the dopaminergic
system (Seeman et al. 2009) might also interfere with learning
and memory processes. It was also demonstrated that the en-
hancement in NMDA-mediated transmission increases fear
response (Yamada et al. 2009). Furthermore, the biological
effects of NMDA receptor antagonists result from their prev-
alence in the central nervous system (Vyklicky et al. 2014). In
line with the results obtained in CFC paradigm, the adminis-
tration of PCP less impaired classically conditioned reaction
to electric stimulation. Thus, the above-mentioned additional
features of PCP might act as a compensating mechanism. It
might mean that SCOP is a stronger pro-amnesic agent and it
impairs not only the quality of re-called information but also
Table 1 Effect of intraperitoneal SCOP and PCP on the duration of
freezing and grooming behavior measured in CFC paradigm. Results
are presented as the mean duration of freezing or grooming behavior ±
SEM for n = 9–10. Statistical analysis: two-way repeated measures
ANOVA followed by Bonferroni multiple comparison test. Significance
vs. control subjected to electric shocks in CFC; *p < 0.05,
****p < 0.0001
Groups Day of
testing
Control not subjected
to electric shocks in CFC
Control subjected to
electric shocks in CFC
SCOP
(CFC mice)
PCP
(CFC mice)
Freezing behavior Day 1 0 0.2 ± 0.2 0 0.1 ± 0.1
Time [s] ± SEM Significance
vs. electric shocks-subjected
CFC control ****p < 0.0001
Day 2 0**** 19.55 ± 5.276 0.5 ± 0.401**** 24 ± 5.723
Grooming behavior Day 1 0.750 ± 0.430 1.950 ± 0.545 2.350 ± 0.553 0.850 ± 0.548
Time [s] ± SEM Significance
vs. electric shocks-subjected
CFC control *p < 0.05
Day 2 3.250 ± 1.389 3.100 ± 1.329 7.150 ± 1.974* 1.000 ± 0.847
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the speed of recall. Of note, the last injections of SCOP and
PCP were made 24 h before the final test. This suggests that
the observed increased locomotion rather did not directly af-
fect the results obtained in BM task.
The comparison of the results from consecutive days of the
acquisition trial confirmed a stronger activity of SCOP than
PCP in BM. Starting from the first day, an increase in primary
and total errors was observed. It indicates that the injection of
SCOP impaired learning abilities and memory. However,
starting with the third day of learning trials, a reduction in
primary errors, but not total errors, occurred. Since on the third
day, a similar reduction of primary and total errors was noticed
in the control group, it could be assumed that after the second
day of memory acquisition trial a specific strengthening of
memory processing might occur. Of note, for PCP this ten-
dency was noticed only if total errors were counted (Fig. 3a).
This preliminary observation seems very interesting but more
detailed studies are needed. If daily results from the acquisi-
tion trial are compared, none of the agents tested significantly
influenced either primary or total time. This analysis was done
in order to evaluate if mice after a 24-h break could immedi-
ately recall the way to the escape box and if a single or repeat-
ed reminding the way to target facilitates memory recall.
Simultaneously, there was an insignificant gradual reduction
of recorded parameters in vehicle-treated and PCP-treated
groups, which might indicate that SCOP-treated mice were
less able to construct spatial memory. Because primary time
was more strongly affected, it can be assumed that the mice
were not motivated enough to enter the escape box to avoid
aversive stimuli. Interestingly, in the SCOP-treated group a
prolongation of both time factors since the second day was
observed, which might indicate the development of memory
impairments and reduction in subjective fear of stimulus.
Significant alterations of locomotor activity of mice might
interfere with the results obtained in BM task. For instance,
increased locomotor activity might lead to the increased num-
ber of errors, which falsely increases this parameter. Both
SCOP and PCP significantly increased locomotor activity of
mice during the first 18 min of the testing period. Thus, if
changes observed for primary and total errors were false pos-
itive, then for every first daily session of the acquisition trial,
we should observe a strong increase in primary and total er-
rors, and this effect should be immediately reduced in the
second daily session. However, this was not observed in our
study, so the results from all sessions were taken for the sta-
tistical analysis.
To conclude, the present study indicates that in the BM task
SCOP is a stronger inductor of spatial memory impairments as
compared to PCP. Moreover, SCOP appears to be a more
potent learning-distractor when the process of classical condi-
tioning is involved. Results of this study taken together with
our previous results (Malikowska et al. 2017) indicate that
SCOP impairs instrumental conditioning (i.e., avoidance
learning), alleviates classical conditioning (i.e., contextual
fear), whereas PCP interferes only with instrumental one
(i.e., avoidance learning) (Malikowska et al. 2017).
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